We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Cephalon (MM) | NASDAQ:CEPH | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 81.49 | 0 | 01:00:00 |
From Jul 2019 to Jul 2024
Goldfarb Branham LLP is investigating the takeover of Cephalon, Inc. (Nasdaq: CEPH) by Teva Pharmaceutical Industries, Ltd. to ensure that shareholders’ rights are preserved in the buyout for $81.50 per share. Concerned Cephalon shareholders are encouraged to contact attorney Hamilton Lindley at 877-583-2855 or hlindley@goldfarbbranham.com about their rights and remedies.
“This buyout is a 6% premium over the previous day’s closing price,” said securities lawyer Hamilton Lindley. “Analysts have placed the price target at between $92 and $119 per share. Our firm’s potential stockholder lawsuit seeks to ensure that investors’ receive the fair price and information that they are entitled to as Cephalon stockholders.”
Goldfarb Branham LLP lawyers have significant experience representing shareholders and whistleblowers in securities lawsuits nationwide. Cephalon investors – or anyone with knowledge about this issue – should contact lawyer Hamilton Lindley at hlindley@goldfarbbranham.com or 877-583-2855.
1 Year Cephalon Chart |
1 Month Cephalon Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
